0001123292-15-001130.txt : 20150821 0001123292-15-001130.hdr.sgml : 20150821 20150821192659 ACCESSION NUMBER: 0001123292-15-001130 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150820 FILED AS OF DATE: 20150821 DATE AS OF CHANGE: 20150821 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS INC CENTRAL INDEX KEY: 0001175505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 260038620 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-365-5600 MAIL ADDRESS: STREET 1: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sarena Francis Willard CENTRAL INDEX KEY: 0001423786 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36070 FILM NUMBER: 151069739 MAIL ADDRESS: STREET 1: C/O FIVE PRIME THERAPEUTICS, INC. STREET 2: 2 CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2015-08-20 0001175505 FIVE PRIME THERAPEUTICS INC FPRX 0001423786 Sarena Francis Willard C/O FIVE PRIME THERAPEUTICS, INC. TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 0 1 0 0 EVP, Gen Counsel & Secretary Common Stock 2015-08-20 4 A 0 75000 0 A 83570 D Represents shares of restricted stock, which will vest according to the following schedule: 50% of the restricted stock vests on September 1, 2016 with the remainder vesting on March 1, 2017, provided the reporting person remains employed by the company through each such date. /s/ Francis Sarena 2015-08-21